Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: A multi-institutional study

Journal of Heart and Lung Transplantation

Volumn 30, Issue 3, 2011, Pages 282-288

  Everitt, Melanie D ^a   Pahl, Elfriede ^b   Schechtman, Kenneth B ^c   Zheng, Jie ^c   Ringewald, Jeremy M ^d   L'Ecuyer, Thomas ^e   Naftel, David C ^f   Kirklin, James K ^f   Blume, Elizabeth D ^g   Bullock, Emily A ^a   Canter, Charles E ^c  

^a UNIVERSITY OF UTAH   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INOTROPIC AGENT;

AGE DETERMINATION; ARTICLE; ASSISTED CIRCULATION; BLOOD GROUP TYPING; CARDIAC GRAFT REJECTION; CHILD; FEMALE; HEART HEMODYNAMICS; HEART TRANSPLANTATION; HEMODYNAMIC COMPROMISE; HEMODYNAMICS; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SURVIVAL RATE;

CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HEMODYNAMICS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 79551687107     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.08.031     Document Type: Article

References (20)

1. R. Kirk, L.B. Edwards, and P. Aurora Registry of the International Society for Heart and Lung Transplantation: eleventh official pediatric heart transplantation report2008 J Heart Lung Transplant 27 2008 970 977
2. M.J. Flippin, D.T. Balzer, and P.R. Murphy Rejection with heart failure after pediatric cardiac transplantation Ann Thorac Surg 68 1999 176 180
3. E. Pahl, D.C. Naftel, C.E. Canter, E.A. Frazier, J.K. Kirklin, W.R. Morrow Pediatric Heart Transplant Study Death after rejection with severe HC in pediatric heart transplant recipients: a multi-institutional study J Heart Lung Transplant 20 2001 279 287 (Pubitemid 32197277)
4. J.G. Gossett, C.E. Canter, and J. Zheng Decline in rejection in the first year after pediatric cardiac transplantation: a multi-institutional study J Heart Lung Transplant 29 2010 625 632
5. E. Pahl, S.E. Crawford, and R.A. Cohn Reversal of severe late left ventricular failure after pediatric heart transplantation and possible role of plasmapheresis Am J Cardiol 85 2000 735 739
6. R.E. Shaddy, D.C. Naftel, J.K. Kirklin Pediatric Heart Transplant Study Outcome of cardiac transplantation in children Survival in a contemporary multi-institutional experience Circulation 94 1996 II69 II73
7. S.A. Webber, D.C. Naftel, and J. Parker Late rejection episodes more than 1 year after pediatric heart transplantation: risk factors and outcomes J Heart Lung Transplant 22 2003 869 875
8. R.M. Mills, D.C. Naftel, J.K. Kirklin Cardiac Transplant Research Database Heart transplant rejection with hemodynamic compromise: a multi institutional study of the role of endomyocardial cellular infiltrate J Heart Lung Transplant 16 1997 813 821
9. S. Stewart, G.L. Winters, M.C. Fishbein, and H.D. Tazelaar Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection J Heart Lung Transplant 24 2005 1710 1720
10. C.Y. Cheung, H.W. Chan, Y.L. Liu, K.F. Chau, and C.S. Li Long-term graft function with tacrolimus and cyclosporine in renal transplantation: paired kidney analysis Nephrology 14 2009 758 763
11. G. Filler, N.J. Webb, and D.V. Milford Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs cyclosporine microemulsion Pediatr Transplant 9 2005 498 503
12. S.R. Knight, N.K. Russell, L. Barcena, and P.J. Morris Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review Transplantation 87 2009 785 794
13. J.A. Kobashigawa, L.W. Miller, and S.D. Russell Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs cyclosporine with MMF in cardiac transplant patients: 1-year report Am J Transplant 6 2006 1377 1386
14. K.R. Kanter, Berg Am, and W.T. Mahle Donor-recipient race mismatch and graft survival after pediatric heart transplantation Ann Thorac Surg 87 2009 204 209
15. O. Cohen, D. De La Zerda, R.E. Beyqui, D. Hekmat, and H. Laks Ethnicity as a predictor of graft longevity and recipient mortality in heart transplantation Transplant Proc 39 2007 3297 3302
16. S.V. Pamboukian, M.R. Costanzo, P. Meyer, L. Bartlett, M. McLeod, and A. Heroux Influence of race in heart failure and cardiac transplantation: mortality differences are eliminated by specialized, comprehensive care J Cardiac Failure 9 2003 80 86
17. V.J. Burroughs, R.W. Maxey, and R.A. Levy Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment J Natl Med Assoc 94 2002 1 26
18. L.M. Mancinelli, L. Frassetto, and L.C. Floren The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups Clin Pharmacol Ther 69 2001 24 31
19. D.M. Girnita, M.M. Brooks, and S.A. Webber Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study Transplantation 85 2008 1632 1639
20. J.E. Ibriham, S.C. Sweet, and M. Flippin Rejection is reduced in thoracic organ recipients when transplanted in the first year of life J Heart Lung Transplant 21 2002 311 318